Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome

Jonathan L. Curry; Victor G. Prieto; Dan M. Jones; Franscisco Vega; Madeleine Duvic; A. Hafeez Diwan

doi:10.1111/j.1600-0560.2009.01459.x

Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome

Jonathan L. Curry, Victor G. Prieto, Dan M. Jones, Franscisco Vega, Madeleine Duvic, A. Hafeez Diwan

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

Immunodeficiency-related lymphoproliferative disorders (IR-LPD) may occur in the setting of immunosuppressive therapy with methotrexate and TNF-α antagonists. As far as we are aware, this is the first report of an Epstein-Barr virus-associated B-cell lymphoproliferative disorder, secondary to methotrexate therapy in a patient with mycosis fungoides/Sézary syndrome.

Original language	English (US)
Pages (from-to)	295-297
Number of pages	3
Journal	Journal of cutaneous pathology
Volume	38
Issue number	3
DOIs	https://doi.org/10.1111/j.1600-0560.2009.01459.x
State	Published - Mar 2011

ASJC Scopus subject areas

Pathology and Forensic Medicine
Histology
Dermatology

Access to Document

10.1111/j.1600-0560.2009.01459.x

Cite this

@article{7132416fb0414b118cf6674a685609b0,

title = "Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/S{\'e}zary syndrome",

abstract = "Immunodeficiency-related lymphoproliferative disorders (IR-LPD) may occur in the setting of immunosuppressive therapy with methotrexate and TNF-α antagonists. As far as we are aware, this is the first report of an Epstein-Barr virus-associated B-cell lymphoproliferative disorder, secondary to methotrexate therapy in a patient with mycosis fungoides/S{\'e}zary syndrome.",

author = "Curry, {Jonathan L.} and Prieto, {Victor G.} and Jones, {Dan M.} and Franscisco Vega and Madeleine Duvic and Diwan, {A. Hafeez}",

year = "2011",

month = mar,

doi = "10.1111/j.1600-0560.2009.01459.x",

language = "English (US)",

volume = "38",

pages = "295--297",

journal = "Journal of cutaneous pathology",

issn = "0303-6987",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome

AU - Curry, Jonathan L.

AU - Prieto, Victor G.

AU - Jones, Dan M.

AU - Vega, Franscisco

AU - Duvic, Madeleine

AU - Diwan, A. Hafeez

PY - 2011/3

Y1 - 2011/3

N2 - Immunodeficiency-related lymphoproliferative disorders (IR-LPD) may occur in the setting of immunosuppressive therapy with methotrexate and TNF-α antagonists. As far as we are aware, this is the first report of an Epstein-Barr virus-associated B-cell lymphoproliferative disorder, secondary to methotrexate therapy in a patient with mycosis fungoides/Sézary syndrome.

AB - Immunodeficiency-related lymphoproliferative disorders (IR-LPD) may occur in the setting of immunosuppressive therapy with methotrexate and TNF-α antagonists. As far as we are aware, this is the first report of an Epstein-Barr virus-associated B-cell lymphoproliferative disorder, secondary to methotrexate therapy in a patient with mycosis fungoides/Sézary syndrome.

UR - http://www.scopus.com/inward/record.url?scp=78751675281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751675281&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0560.2009.01459.x

DO - 10.1111/j.1600-0560.2009.01459.x

M3 - Article

C2 - 19889052

AN - SCOPUS:78751675281

SN - 0303-6987

VL - 38

SP - 295

EP - 297

JO - Journal of cutaneous pathology

JF - Journal of cutaneous pathology

IS - 3

ER -

Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this